Quantum Genomics (France) Price on February 6, 2024
ALQGC Stock | EUR 0.07 0 1.77% |
If you're considering investing in Quantum Stock, it is important to understand the factors that can impact its price. As of today, the current price of Quantum Genomics stands at 0.07, as last reported on the 29th of November, with the highest price reaching 0.07 and the lowest price hitting 0.07 during the day. Quantum Genomics is out of control given 3 months investment horizon. Quantum Genomics maintains Sharpe Ratio (i.e., Efficiency) of 0.15, which implies the firm had a 0.15% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 5.95% are justified by taking the suggested risk. Use Quantum Genomics Semi Deviation of 13.45, risk adjusted performance of 0.1238, and Coefficient Of Variation of 672.5 to evaluate company specific risk that cannot be diversified away.
Quantum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Quantum |
Sharpe Ratio = 0.1489
Best Portfolio | Best Equity | ALQGC | ||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
39.97 actual daily | 96 96% of assets are less volatile |
Expected Return
5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Quantum Genomics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Quantum Genomics by adding it to a well-diversified portfolio.
Quantum Genomics Valuation on February 6, 2024
It is possible to determine the worth of Quantum Genomics on a given historical date. On February 6, 2024 Quantum was worth 0.1 at the beginning of the trading date compared to the closed value of 0.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Quantum Genomics stock. Still, in general, we apply an absolute valuation method to find Quantum Genomics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Quantum Genomics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Quantum Genomics' related companies.
Open | High | Low | Close | Volume | |
0.10 | 0.11 | 0.10 | 0.10 | 32,455 | |
02/06/2024 | 0.10 | 0.11 | 0.10 | 0.10 | 69,447 |
0.10 | 0.10 | 0.10 | 0.10 | 24,124 |
Backtest Quantum Genomics | | | Quantum Genomics History | | | Quantum Genomics Valuation | Previous | Next |
Quantum Genomics Trading Date Momentum on February 6, 2024
On February 07 2024 Quantum Genomics SA was traded for 0.10 at the closing time. The highest price during the trading period was 0.10 and the lowest recorded bid was listed for 0.10 . The volume for the day was 24.1 K. This history from February 7, 2024 did not cause price change. The trading delta at closing time to the current price is 10.00% . |
Quantum Genomics Fundamentals Correlations and Trends
By evaluating Quantum Genomics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Quantum Genomics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Quantum financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Quantum Genomics Stock history
Quantum Genomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Quantum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Quantum Genomics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Quantum Genomics stock prices may prove useful in developing a viable investing in Quantum Genomics
Quantum Genomics Socit Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It is also developing QGC011 that is in pre-clinical phase to treat hypertension with combination therapy and QGC006 to optimize the treatment of hypertension with a monotherapy drug. QUANTUM GENOMICS operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 13 people.
Quantum Genomics Stock Technical Analysis
Quantum Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Quantum Genomics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Quantum Genomics SA cannot be verified against its exchange. Please verify the symbol is currently traded on Euronext Paris. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Quantum Genomics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Quantum Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quantum Genomics shares will generate the highest return on investment. By undertsting and applying Quantum Genomics stock market strength indicators, traders can identify Quantum Genomics SA entry and exit signals to maximize returns
Quantum Genomics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Quantum Genomics' price direction in advance. Along with the technical and fundamental analysis of Quantum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Quantum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1238 | |||
Jensen Alpha | 6.33 | |||
Total Risk Alpha | (0.08) | |||
Sortino Ratio | 0.2599 | |||
Treynor Ratio | (1.39) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Quantum Stock Analysis
When running Quantum Genomics' price analysis, check to measure Quantum Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quantum Genomics is operating at the current time. Most of Quantum Genomics' value examination focuses on studying past and present price action to predict the probability of Quantum Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quantum Genomics' price. Additionally, you may evaluate how the addition of Quantum Genomics to your portfolios can decrease your overall portfolio volatility.